Effect of taurine in liver transplantatio

Phase 3

• Conditions: iver transplantation.; Other complications of liver transplant; T86.49

• Registration Number: IRCT20200312046755N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

All the patients older than 18 who are candidates for liver transplantation in Abu-Ali Sina hospital of Shiraz
Hospitalization for at least 1 week after liver transplantation in Abu-Ali Sina hospital of Shiraz
Filling the inclusion consent form by the patient

Exclusion Criteria

Allergy to taurine
Lack of consent
Pregnancy and lactation
Simultaneous liver and kidney transplantation
Parenteral nutrition containing parenteral amino acids,
Heart failure
Lithium

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of the transplanted liver function regarding hepatic enzymes. Timepoint: Within the first month after transplantation. Method of measurement: Via studying the patient's file's data.;Prevention of acute rejection of the transplanted organ. Timepoint: Within the first month after transplantation. Method of measurement: Diagnosis and confirmation by the related physician.

Secondary Outcome Measures

Name	Time	Method
Rate of new-onset diabetes after transplantation. Timepoint: Within the first month after transplantation. Method of measurement: Laboratory data related to serum glucose and HbA1C.;Rate of delirium development. Timepoint: Within the first month after transplantation. Method of measurement: CAM-ICU score.